Home › Blog › Q&A › The Hexenoyl Modification

What Is the Modification in Tesamorelin?

Published 2026-10-26 · REVIVE Peptides Research Desk · 1 min read
Short answer: A trans-3-hexenoyl group — a six-carbon unsaturated acyl chain — attached to the amino terminus of the first residue, tyrosine, of the full 44-residue human GHRH sequence. Natural GHRH is cut between its second and third residues by the enzyme DPP-4 within minutes; the hexenoyl group blocks that cut, so tesamorelin persists long enough to act.

Apart from that group the sequence is the natural one, which is why tesamorelin is described as a GHRH analogue rather than a new peptide. Its mass, ≈5136 Da, is the mass of GHRH(1-44) amide plus the hexenoyl group.

The modification is also what distinguishes it chemically from sermorelin, which is the first 29 residues of GHRH without any protecting group.

REVIVE LAB UAE supplies the pack for laboratory research use only. It is not for human or veterinary use, and no dosing, administration or protocol guidance is provided.

Tesamorelin Pack 20 mg — REVIVE LAB UAE
AED 1010 · Lot-specific COA on request · Cash on delivery or USDT (5% off) Order Tesamorelin Pack UAE — Live Stock & Pricing
Research-Use Only Disclaimer: This page is published for laboratory and scientific research information purposes only. Nothing here constitutes medical advice, dosing guidance, or a therapeutic recommendation. Products supplied by REVIVE LAB UAE (revivelab.ae) — where applicable — are sold strictly as reference materials for research use, not for human or veterinary consumption. Buyers and readers are solely responsible for compliance with applicable UAE laws and institutional research ethics requirements.